Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03109613 · ClinicalTrials.gov registry record · Phase 1
PEEP and V/Q Mismatch in Premature Infants
A Phase 1 study, sponsored by Children's Hospital of Philadelphia.
- Terminated
- Registry status
- Phase 1
- Development phase
- 12
- Enrollment target
NCT03109613 is a Phase 1 study that was terminated before completion, run by Children's Hospital of Philadelphia. The registered enrollment target is 12 participants.
The verdict
NCT03109613, a Phase 1 study, was terminated before completion, sponsored by Children's Hospital of Philadelphia.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 12 participants
- Enrollment target
Study Summary
Positive end-expiratory pressure (PEEP) is used in premature infants receiving mechanical ventilation to maintain lungs open and facilitate gas exchange. When ventilation/perfusion mismatch is present, areas of the lung that are open for gas exchange do not match up with areas of the lung that are receiving blood for gas exchange. This study measures the feasibility of enrolling and completing study maneuvers in premature infants for a prospective study measuring the responsiveness of V/Q mismatch to changes in the amount (or level) of PEEP.
Interventions
- DEVICE Positive end-expiratory pressure (PEEP)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2016-04-11 |
| Est. Completion | 2018-08-08 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03109613
The ClinicalTrials.gov registry entry for NCT03109613 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Hospital of Philadelphia, which has 431 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Positive end-expiratory pressure (PEEP) is the first listed.
NCT03109613 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03109613 about?
NCT03109613 is a clinical study titled "PEEP and V/Q Mismatch in Premature Infants". Positive end-expiratory pressure (PEEP) is used in premature infants receiving mechanical ventilation to maintain lungs open and facilitate gas exchange. When ventilation/perfusion mismatch is present, areas of the lung that are open for gas exchange do not match up with areas of the lung that are r...
What is the current status of trial NCT03109613?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 12 participants. The study started on 2016-04-11. Estimated completion is 2018-08-08.
What interventions are being tested in trial NCT03109613?
The interventions under investigation include: Positive end-expiratory pressure (PEEP) (DEVICE).
Who is sponsoring clinical trial NCT03109613?
This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.